Have you listened yet? Exciting news in Proteomics! 🔬🎙️ Tune in to the debut of the Alamar podcast series with Mendelspod host Theral Timpson as he sits down with Alamar CEO, Yuling Luo, and discusses groundbreaking advancements in the #proteomics industry, the future of protein #biomarker detection, and how our #NULISA and #ARGO HT technology is impacting research in the hot areas of #Alzheimer’s and inflammatory disease. 🔗 Listen now! https://ow.ly/SGgf50SuR4q
Alamar Biosciences, Inc.
Biotechnology Research
Fremont, California 12,211 followers
Powering Precision Proteomics with unrivaled sensitivity and simplicity
About us
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. The NULISAseq Inflammation Panel contains 200+ important markers related to immune and inflammatory diseases and will run on our ARGO™ System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands on time from sample to data.
- Website
-
http://www.alamarbio.com
External link for Alamar Biosciences, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Fremont, California
- Type
- Privately Held
- Founded
- 2018
Locations
-
Primary
47071 Bayside Pkwy
Fremont, California 94538, US
Employees at Alamar Biosciences, Inc.
Updates
-
Alamar Biosciences, Inc. reposted this
The stars are aligning in Alzheimer’s research like never before. We talk with Dr. Henrik Zetterberg about the current excitement around #Alzheimer’s research on @mendelspod #biomarkers #proteomics Alamar Biosciences, Inc. https://lnkd.in/gmBygv3h
-
🎙️ Exciting News! Join us for the latest episode of Mendelspod as we deep dive into the groundbreaking advancements in #Alzheimer's research with Dr. Henrik Zetterberg, one of the world's leading experts from the University of Gothenburg. 🧠 Until recently, Alzheimer’s research faced immense challenges, but today, the tide has turned. Discover how the field has surged forward with new hope, FDA-approved drugs, and promising biomarkers and innovative technologies (like #NULISA) that could transform early diagnosis and treatment. New episode out now 👉 https://ow.ly/FJ6150Sxr08
-
Happening today! Join Xiao-Jun Ma, CTO at Alamar, during the Satellite Symposium, for a fireside chat on Translating Innate and Adaptive Immune Therapies. Tune in at 16:35 to get an exclusive look at the cutting-edge capabilities of #NULISA and the #ARGO HT System. See you there 👋 https://ow.ly/XxvC50StlXQ #immunology #proteomics
-
✈ We're headed to Berlin! Join us on July 3 for a discussion on the latest advances in protein biomarker research where local scientists will present their recent discoveries utilizing our #NULISA and #ARGO HT technology for high sensitivity protein detection. 👉 Click the link to register! https://bit.ly/4eGbALl
-
We are here live at the 2nd Annual Symposium for Human Proteome and Health in Oxford, UK! Join Alamar's Alex Forrest-Hay at 09:45 during the Advances in Proteomics Technology session for an exclusive look at the next generation of #proteomics technology and learn about the cutting-edge capabilities of #NULISA. Learn more 👉 https://ow.ly/Wr6t50SqxbW
-
Alamar Biosciences, Inc. reposted this
📣 ICYMI! Tune in to hear Mendelspod's Theral Timpson and our CEO, Yuling Luo, discuss the current proteomics industry, the future of protein biomarker detection, and how our #NULISA and #ARGO HT technology is impacting research in the hot areas of Alzheimer’s and inflammatory disease. Full episode out now 👉 https://lnkd.in/gWq93q3e
-
Exciting news! We are joining forces with the Biomarkers of Aging Consortium to revolutionize longevity research! Read the release! https://ow.ly/L6fg50SqSIk
-
📣 ICYMI! Tune in to hear Mendelspod's Theral Timpson and our CEO, Yuling Luo, discuss the current proteomics industry, the future of protein biomarker detection, and how our #NULISA and #ARGO HT technology is impacting research in the hot areas of Alzheimer’s and inflammatory disease. Full episode out now 👉 https://lnkd.in/gWq93q3e